Trypanosoma cruzi infection in puerperal women and their neonates at Barcelona, Anzoategui State, Venezuela

Norielis del Carmen Zabala, Mariolga Berrizbeitia, Alicia Jorquera, Jessicca Rodríguez, Leomery Romero, .

Keywords: Trypanosoma cruzi, Chagas diseases/diagnosis, newborn, enzyme-linked immunosorbent assay, Venezuela

Abstract

Introduction. Trypanosoma cruzi is mainly transmitted by vectors. Other pathways such as oral and congenital transmission have become increasingly relevant.
Objective. To evaluate T. cruzi infections in post-partum women and their newborns who attended the Hospital Universitario Dr. Luis Razetti (Barcelona, Anzoátegui state, Venezuela).
Materials and methods. A prospective cross-sectional study was undertaken from May, 2015, to August, 2016. ELISA, MABA and IFI assays were used to determine the infection in 1,200 post-partum women. The newborns of seropositive women were then examined for T. cruzi by PCR amplification and serological tests at nine months old. The prevalence of the parasitic infection in post-partum women and their newborns was then estimated. To establish the relationship between risk factors and infection, the chi-square test (c2) and the probability ratio (OR) was applied.
Results. A total of 78 women were identified as seropositive (6.50 %) (CI 95%: 5.10-7.89%), and parasitic DNA was detected in six of their newborns (9.09%). Nine months after birth eleven infants were examined, and all were found to be serologically negative. Risk factors detected were pregnancy duration (OR: 0,36; CI95%: 0,15-0,84), where the patients lived at present (OR: 0,34; CI95%: 0,24-0,62) or previously (OR: 2,50; CI95%: 1,38-4,52) and having relatives with Chagas disease (OR: 1,75; CI95%: 1,02-3,01).
Conclusions. Seroprevalence for T. cruzi infection in young post-partum women in rural areas was high. The detection of parasite DNA at birth was not indicative of congenital Chagas disease.

Downloads

Download data is not yet available.
  • Norielis del Carmen Zabala Posgrado en Biología Aplicada, Universidad de Oriente, Núcleo de Sucre, Cumaná, Venezuela
  • Mariolga Berrizbeitia Posgrado en Biología Aplicada, Universidad de Oriente, Núcleo de Sucre, Cumaná, Venezuela; Instituto de Investigaciones en Biomedicina y Ciencias Aplicadas, Universidad de Oriente, Cumaná, Venezuela https://orcid.org/0000-0001-5003-2586
  • Alicia Jorquera Centro de Investigaciones en Ciencias de la Salud, Universidad de Oriente, Núcleo de Anzoátegui, Barcelona, Venezuela
  • Jessicca Rodríguez Instituto de Investigaciones en Biomedicina y Ciencias Aplicadas, Universidad de Oriente, Cumaná, Venezuela
  • Leomery Romero Centro de Investigaciones en Ciencias de la Salud, Universidad de Oriente, Núcleo de Anzoátegui, Barcelona, Venezuela

References

World Health Organization. Chagas disease in Latin America: An epidemiological update based on 2010 estimates. Wkly Epidemiol Rec. 2015;90:33-43.

Molina I, Salvador F, Sánchez A. Update Chagas disease. Enferm Infecc Microbiol Clin. 2016;34:132-8. https://doi.org/10.1016/j.eimc.2015.12.008

Carlier Y, Sosa S, Luquetti A, Buekens P. Congenital Chagas disease: An update. Mem Inst Oswaldo Cruz. 2015;110:363-8. https://doi.org/10.1590/0074-02760140405

Colimon KM. Fundamentos de epidemiología. Tercera edición. Medellín: Coorporación para Investigaciones Biológicas; 2010. p. 551.

Bezares B, Sanz O, Jiménez I. Puerperal pathology. An Sist Sanit Navar. 2009;32:169-75. https://doi.org/10.23938/ASSN.0184

Berrizbeitia M, Seijas N, Rodríguez J, Jorquera A, Romero L. Estandarización, validación de la prueba de inmunofluorescencia indirecta y su uso en un estudio epidemiológico de la infección por Trypanosoma cruzi, en una comunidad rural del estado Sucre, Venezuela. Revista de la Sociedad Venezolana de Microbiología. 2015;35:53-9.

Ndao M, Kelly N, Normandin D, Maclean J, Whiteman A, Kokoskin E, et al. Trypanosoma cruzi infection of squirrel monkeys: Comparison of blood smear examination, commercial enzyme-linked immunosorbent assay, and polymerase chain reaction analysis as screening tests for evaluation of monkey-related injuries. Comp Med. 2000;50:658-65.

Berrizbeitia M, Ndao M, Bubis J, Gottschalk M, Aché A, Lacouture S, et al. Field evaluation of four novel enzyme immunoassays for Chagas’ disease in Venezuela blood banks: Comparison of assays using fixed-epimastigotes, fixed-trypomastigotes or trypomastigote excreted-secreted antigens from two Trypanosoma cruzi strains. Transfus Med. 2006;16:419-31. https://doi.org/10.1111/j.1365-3148.2006.00703.x

Noya O, Alarcón de Noya B. The multiple antigen blot assay (MABA): A simple immunoenzimatic technique for simultaneous screening of multiple antigens. Immunol Lett. 1998;63:53-6. https://doi.org/10.1016/S0165-2478(98)00055-8

Berrizbeitia M, Estaba A, Pozo A, Jorquera A, Rodulfo H. Comparación entre dos pruebas de reacción en cadena de la polimerasa (PCR satélite y PCR kinetoplasto) para la detección de ADN de Trypanosoma cruzi en heces de triatominos. Saber. 2017;29:767-74.

Mendoza C, Córdova E, Juárez J, Saldaña J, Torres A, Velásquez R, et al. The prevalence of Chagas’ disease in puerperal women and congenital transmission in an endemic area of Perú. Rev Panam Salud Pública. 2005;17:147-53.

Cardoso E, Valdez G, Campos AC, De la Luz-Sánchez R, Mendoza CR, Hernández AP, et al. Maternal fetal transmission of Trypanosoma cruzi: A problem of public health little studied in México. Exp Parasitol. 2012;131:425-32. https://doi.org/10.1016/j.exppara.2012.05.013

Castellanos-Domínguez Y, Cucunubá ZM, Orozco LC, Valencia-Hernández CA, León CM, Flórez AC, et al. Risk factors associated with Chagas disease in pregnant women in Santander, a highly endemic Colombian area. Trop Med Int Health. 2016;21:140-8. https://doi.org/10.1111/tmi.12634

Carrera C, Narváez AO, Muzzio J, Shiguango G, Robles LM, Herrera C, et al. Seroprevalence of Trypanosoma cruzi infection in schoolchildren and in pregnant women from an Amazonian Region in Orellana Province, Ecuador. Am J Trop Med Hyg. 2015;93:774-8. https://doi.org/10.4269/ajtmh. 14-0807

Brutus L, Castillo H, Bernal C, Salas NA, Schneider D, Santalla JA, et al. Detectable Trypanosoma cruzi parasitemia during pregnancy and delivery as a risk factor for congenital Chagas disease. Am J Trop Med Hyg. 2010;83:1044-7. https://doi.org/10.4269/ajtmh .2010.10-0326

Kaplinski M, Jois M, Galdós-Cárdenas G, Rendell VR, Shah V, Do RQ, et al. Sustained domestic vector exposure is associated with increased Chagas cardiomyopathy risk but decreased parasitemia and congenital transmission risk among young women in Bolivia. Clin Infect Dis. 2015;61:918-26. https://doi.org/10.1093/cid/civ446

Sosa-Estani S, Dri L, Touris C, Abalde S, Dell’arciprete A, Braunstein J. Vectorial and congenital transmission of Trypanosoma cruzi in Las Lomitas, Formosa. Medicina (B. Aires). 2009;69:424-30.

Mastrolonardo V, Ramos D, Paravisini I, Morales J. Tripanosomiasis en el embarazo. Rev Obstet Ginecol Venez. 2013;73:149-56.

Alarcón de Noya B, Pérez G, Díaz Z, Dickson S, Muñoz A, Hernández C, et al. Description of an oral Chagas disease outbreak in Venezuela, including a vertically transmitted case. Mem Inst Oswaldo Cruz. 2017;112:569-71. https://doi.org/10.1590/0074-027601700 09

Carlier Y, Truyens C. Congenital Chagas disease as an ecological model of interactions between Trypanosoma cruzi parasites, pregnant women, placenta and fetuses. Acta Trop. 2015;151:103-15. https://doi.org/10.1016/j.actatropica.2015.07.016

Zingales B, Miles M, Campbell DA, Tibayrenc M, Macedo AM, Teixeira MM, et al. The revised Trypanosoma cruzi subspecific nomenclature: Rationale, epidemiological relevance and research applications. Infect Genet Evol. 2012;12:240-53. https://doi.org/10.1016/j.meegid.2011.12.00

Gomes Y, Lorena V, Luquetti A. Diagnosis of Chagas disease: What has been achieved? What remains to be done with regard to diagnosis and follow up studies? Mem Inst Oswaldo Cruz. 2009;104:115-21. https://doi.org/10.1590/S0074-02762009000900017

Apt W, Zulantay I, Arnello M, Oddó D, González S, Rodríguez J, et al. Congenital infection by Trypanosoma cruzi in an endemic area of Chile: A multidisciplinary study. Trans R Soc Trop Med Hyg. 2013;107:98-104. https://doi.org/10.1093/trstmh/trs013

Carlier Y, Torrico F. Congenital infection with Trypanosoma cruzi: From mechanisms of transmission to strategies for diagnosis and control. Rev Soc Bras Med Trop. 2003;36:767-71.

Campos G, Canseco L, González F, Alfaro O, Nava I, Jiménez E. Transmisión materno-fetal de Trypanosoma cruzi, un problema de salud poco estudiado en México: caso Chiapas. Salud Pública Mex. 2016;58:378-84.

Brasil P, De Castro L, Hasslocher A, Sangenis L, Braga J. ELISA versus PCR for diagnosis of chronic Chagas disease: Systematic review and meta-analysis. BMC Infect Dis. 2010;10:337. https://doi.org/10.1186/1471-2334-10-337

Castro AM, Luquetti AO, Rassi A, Rassi GG, Chiari E, Galvão LM. Blood culture and polymerase chain reaction for the diagnosis of the chronic phase of human infection with Trypanosoma cruzi. Parasitol Res. 2002;88:894-900. https://doi.org/10.1007/s00436-002-0679-3

Bern C, Verastegui M, Gilman R, La Fuente C, Galdós-Cárdenas G, Calderón M, et al. Congenital Trypanosoma cruzi transmission in Santa Cruz, Bolivia. Clin Infect Dis. 2009;49:1667-74. https://doi.org/10.1086/648070

De Rissio AM, Riarte AR, García M, Esteva M, Quaglino M, Ruiz A. Congenital Trypanosoma cruzi infection. Efficacy of its monitoring in an urban reference health center in a non-endemic area of Argentina. Am J Trop Med Hyg. 2010;82:838-45. https://doi.org/10.4269/ajtmh.2010.08-0383

Ortí R, Parada M. Prevalencia de tripanosomiasis americana en mujeres gestantes de un área de salud. Valencia, 2005-2007. Rev Esp Salud Pública. 2009;83:543-55.

Cucunubá Z, Valencia C, Flórez C, León Y, Castellanos A, Cárdenas P, et al. Pilot program for surveillance of congenital Chagas disease in Colombia 2010-2011. Int J Infect Dis. 2012;16:e343.

Cucunubá Z, Florez A, Cárdenas A, Pavía P, Montilla M, Aldana R, et al. Prevalence and risk factors for Chagas disease in pregnant women in Casanare, Colombia. Am J Trop Med Hyg. 2012;87:837-42. https://doi.org/10.4269/ajtmh.2012.12-0086

Cevallos AM, Hernández R. Chagas’ disease: Pregnancy and congenital transmission. Biomed Res Int. 2014;2014:401864. https://doi.org/10.1155/2014/401864

Ávila O, Liendo P, Martínez L, Martínez T, Pocheville MI, Egurbide MV. Prevalence of Trypanosoma cruzi infection and vertical transmission in Latin-American pregnant women in a health area of Biscay. Enferm Infecc Microbiol Clin. 2013;31:210-6. https://doi.org/10.1016/j.eimc.2012.01.029

Torrico F, Alonso-Vega C, Suárez E, Rodríguez P, Torrico MC, Dramaix M, et al. Maternal Trypanosoma cruzi infection, pregnancy outcome, morbidity, and mortality of congenitally infected and non-infected newborns in Bolivia. Am J Trop Med Hyg. 2004;70:201-9.

Sanmartino M, Crocco CL. Conocimientos sobre la enfermedad de Chagas y factores de riesgo en comunidades epidemiológicamente diferentes de Argentina. Rev Panam Salud Pública. 2000;7:173-8.

Sasagawa E, Aiga H, Corado EY, Cuyuch BL, Hernández MA, Guevara AV, et al. Risk factors for Chagas disease among pregnant women in El Salvador. Trop Med Int Health. 2015;20:268-76. http://doi.org/10.1111/tmi.12440

How to Cite
1.
Zabala N del C, Berrizbeitia M, Jorquera A, Rodríguez J, Romero L. Trypanosoma cruzi infection in puerperal women and their neonates at Barcelona, Anzoategui State, Venezuela. biomedica [Internet]. 2019 Dec. 1 [cited 2024 Jul. 2];39(4):769-84. Available from: https://revistabiomedica.org/index.php/biomedica/article/view/4606

Some similar items:

Published
2019-12-01
Section
Original articles

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
QR Code